2023 World Conference on Lung Cancer (Posters)-EP16.01. A Brief History of Lung Cancer in Canada: Care, Contributions and Challenges

Pdf Summary

This presentation discusses the history of lung cancer in Canada and the contributions made by Canadian researchers in advancing lung cancer knowledge and treatment. Lung cancer has been the most common and deadly cancer in Canada for over a century, primarily due to high tobacco exposure and other risk factors. The researchers conducted a review of literature from 105 sources to highlight Canadian contributions, current challenges, and future directions. <br /><br />While lung cancer rates are decreasing, the absolute number of cases continues to rise as Canada's population grows and ages. The researchers discuss various screening trials, ranging from chest x-ray and sputum cytology studies to low dose CT screening trials. Canadian researchers have made significant contributions to the diagnostic workup, including studies on endobronchial ultrasound and PET scan staging. Canadian thoracic surgeons have also contributed important surgical techniques for lung cancer resection.<br /><br />In systemic therapy, Canadian-led trials have played a pivotal role in advancing treatments for lung cancer. These trials include testing erlotinib in previously treated non-small cell lung cancer (NSCLC), adjuvant vinorelbine and cisplatin in resected NSCLC, immunotherapy in extensive small cell lung cancer (SCLC), and neoadjuvant Nivolumab and chemotherapy. Canadian researchers have also made significant contributions to radiotherapy innovations for lung cancer treatment.<br /><br />Challenges still persist in Canada, particularly in terms of equity and access to lung cancer screening and treatment. Outcomes for Canadian women and disadvantaged populations have fallen behind those of other countries. Lung cancer screening remains limited in certain parts of Canada. Addressing these challenges is a priority for organizations such as Lung Cancer Canada.<br /><br />Overall, the history of lung cancer care in Canada and the contributions made by Canadian researchers provide hope for the future. However, more progress is needed, particularly in addressing equity and access issues.

Asset Subtitle

Stéphanie Mercier

Meta Tag

Speaker Stéphanie Mercier

Topic Patient Advocacy

Keywords

lung cancer

Canada

Canadian researchers

tobacco exposure

screening trials

diagnostic workup

systemic therapy

radiotherapy innovations

equity

access